Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
M7824+paclitaxel
1 trial
phase_1_2
yonsei-university
Trastuzumab + Ramucirumab + Paclitaxel
1 trial
phase_1_2
yonsei-university
2 unique interventions1 categories

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04835896Phase 1/2Completed
Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer
Recurrent/Metastatic Gastric Cancer
PrincipalinvestigatorStart date: 2021-06-02
NCT04888663Phase 1/2Unknown
Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)
Recurrent/Metastatic Gastric Cancer
PrincipalinvestigatorStart date: 2018-02-13

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Recurrent/Metastatic Gastric Cancer2

Affiliations

Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

1 similar investigators found

SUN YOUNG Rha

Yonsei Cancer Center, Yonsei University College of Medicine

Moderately Similar
6 trials

Shared therapeutic areas:

Recurrent/Metastatic Gastric Cancer

Worked with same sponsors:

Yonsei University
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04835896Phase 1/2PrincipalInvestigator

Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer

Recurrent/Metastatic Gastric Cancer
Completed
NCT04888663Phase 1/2PrincipalInvestigator

Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)

Recurrent/Metastatic Gastric Cancer
Unknown

All 2 trials loaded